Key Drivers
- Liquidity Strength
- Margin Compression
- SBC Burden
AIAI Summary
INSP is no longer a clean growth story but a repair case: the core sleep-apnea market remains attractive, yet the stock likely stays under pressure until management proves it can fix reimbursement/coding friction and stabilize Inspire V rollout volumes, with the strong cash position only buying time rather than restoring credibility.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Liquidity Strength
- •Margin Compression
- •SBC Burden
INSP posted strong full-year cash generation and a fortress balance sheet, but the latest quarter showed operating profit pressure and heavy share-based compensation that weighs on earnings quality.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Support test
- •Rebound failure
INSP remains bearish after a sharp drop over the last month, with $40 support in play and only a move back above $44-$45 improving the near-term setup.
Sharp ~30% selloff since 2026-04-17 with acceleration lower after 2026-05-01 suggests oversold bounce risk
Sentiment & News
Key News Insights:
- •Guidance cut
- •Reimbursement pressure
- •Procedure slowdown
INSP beat Q1 estimates, but a cut to 2026 guidance and ongoing reimbursement, coding, and competition pressures keep the stock outlook cautious.
The earnings beat is likely overshadowed by weaker forward guidance and operational headwinds, keeping near-term sentiment negative
Similar Companies in Healthcare
Other companies in the same sector with AI ratings